BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21671119)

  • 1. An abundant, truncated human sulfonylurea receptor 1 splice variant has prodiabetic properties and impairs sulfonylurea action.
    Schmid D; Stolzlechner M; Sorgner A; Bentele C; Assinger A; Chiba P; Moeslinger T
    Cell Mol Life Sci; 2012 Jan; 69(1):129-48. PubMed ID: 21671119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.
    Tarasov AI; Nicolson TJ; Riveline JP; Taneja TK; Baldwin SA; Baldwin JM; Charpentier G; Gautier JF; Froguel P; Vaxillaire M; Rutter GA
    Diabetes; 2008 Jun; 57(6):1595-604. PubMed ID: 18346985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
    Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
    J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM; Tucker SJ; Seino S; Ashcroft FM
    Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered functional properties of KATP channel conferred by a novel splice variant of SUR1.
    Sakura H; Trapp S; Liss B; Ashcroft FM
    J Physiol; 1999 Dec; 521 Pt 2(Pt 2):337-50. PubMed ID: 10581306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered interaction between SUR1 and Kir6.2 that enhances ATP sensitivity in KATP channels.
    Pratt EB; Zhou Q; Gay JW; Shyng SL
    J Gen Physiol; 2012 Aug; 140(2):175-87. PubMed ID: 22802363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
    Chan KW; Wheeler A; Csanády L
    J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
    Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
    Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic K(ATP) channels cause neonatal diabetes by perturbing the coupling between Kir6.2 and SUR1 subunits.
    Lin YW; Akrouh A; Hsu Y; Hughes N; Nichols CG; De León DD
    Channels (Austin); 2012; 6(2):133-8. PubMed ID: 22562119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KATP channel subunits in rat dorsal root ganglia: alterations by painful axotomy.
    Zoga V; Kawano T; Liang MY; Bienengraeber M; Weihrauch D; McCallum B; Gemes G; Hogan Q; Sarantopoulos C
    Mol Pain; 2010 Jan; 6():6. PubMed ID: 20102598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
    Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
    J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential K(ATP) channel pharmacology in intact mouse heart.
    Glukhov AV; Flagg TP; Fedorov VV; Efimov IR; Nichols CG
    J Mol Cell Cardiol; 2010 Jan; 48(1):152-60. PubMed ID: 19744493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload.
    Hu X; Xu X; Huang Y; Fassett J; Flagg TP; Zhang Y; Nichols CG; Bache RJ; Chen Y
    Circ Res; 2008 Oct; 103(9):1009-17. PubMed ID: 18802029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of KATP channel expression and activity by the SUR1 nucleotide binding fold 1.
    Masia R; Caputa G; Nichols CG
    Channels (Austin); 2007; 1(4):315-23. PubMed ID: 18708750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H3 domain of syntaxin 1A inhibits KATP channels by its actions on the sulfonylurea receptor 1 nucleotide-binding folds-1 and -2.
    Cui N; Kang Y; He Y; Leung YM; Xie H; Pasyk EA; Gao X; Sheu L; Hansen JB; Wahl P; Tsushima RG; Gaisano HY
    J Biol Chem; 2004 Dec; 279(51):53259-65. PubMed ID: 15485808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity.
    Pu JL; Ye B; Kroboth SL; McNally EM; Makielski JC; Shi NQ
    J Mol Cell Cardiol; 2008 Jan; 44(1):188-200. PubMed ID: 18001767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ABCC8 (SUR1)-dependent mechanism of metabolism-excitation uncoupling.
    Babenko AP
    J Biol Chem; 2008 Apr; 283(14):8778-82. PubMed ID: 18281290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
    Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
    Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ontogeny of sulphonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium].
    Lovász N; Ducza E; Gáspár R; Falkay G
    Acta Pharm Hung; 2011; 81(3):101-7. PubMed ID: 22165413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
    J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.